PASI90 response: the new standard in therapeutic efficacy for psoriasis von Puig, L.

Volltext

Head‐to‐head comparison of biologics in psoriasis: better acceleration does not necessarily win all races von Puig, L.

Volltext

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment von Puig, L.

Volltext

Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4‐week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?... von Puig, L.

Volltext

Significant weight loss improves and prevents psoriasis and psoriatic arthritis in obese patients: a Critically Appraised Topic and a call to action von Puig, L.

Volltext

Epidemiology of atopic dermatitis in adults: Results from an international survey von Barbarot, S., Auziere, S., Gadkari, A., Girolomoni, G., Puig, L., Simpson, E. L., Margolis, D. J., Bruin‐Weller, M., Eckert, L.

Volltext

British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infections von Puig, L.

Volltext

Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others von Puig, Lluís

Volltext

Choice of first‐line biologic therapy in psoriasis: understanding the past and shaping the future? von Puig, L.

Volltext

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis von Puig, L

Volltext

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis von Puig, L.

Volltext

Registries and biologics: disease populations matter von Puig, L.

Volltext

Interleukin-17 in skin: psoriasis and yonder von Puig, L.

Volltext

Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management von Saunte, D.M., Mrowietz, U., Puig, L., Zachariae, C.

Volltext

European consensus statement on phenotypes of pustular psoriasis von Navarini, A.A., Burden, A.D., Capon, F., Mrowietz, U., Puig, L., Köks, S., Kingo, K., Smith, C., Barker, J.N., Bachelez, Hervé, Chiricozzi, Andrea, Costanzo, Antonio, Eyerich, Kilian, French, Lars E., Ghoreschi, Kamran, Gilliet, Michel, Girolomoni, Giampiero, Gniadecki, Robert, Griffiths, Christopher, Koh, Hong Yi, Lipsker, Dan, Naldi, Luigi, Prans, Ele, Prinz, Jörg, Reich, Kristian, Röcken, Martin, Skov, Lone, Sorin, George, Ståhle, Mona, Stingl, Georg, Van de Kerkhof, Peter, Warren, Richard

Volltext

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons von Puig, L

Volltext

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018 von Puig, L.

Volltext

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons von Puig, L.

Volltext

A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain von Bhatt, Dhaval P, Puig, Kendra L, Gorr, Matthew W, Wold, Loren E, Combs, Colin K

Volltext

Biosimilars in psoriasis 2015: what is next? von Puig, L.

Volltext